Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Natascha Marquardt"'
Autor:
Christian Qvigstad, Lars Q. Sørensen, Geir E. Tjønnfjord, Pål André Holme, Ingrid Pabinger, Cedric Hermans, Roseline d’Oiron, Robert Klamroth, Johannes Oldenburg, Natascha Marquardt, Peter Staritz, Olga Katsarou, Uri Martinowitz, Aharon Lubetsky, Gili Kenet, Annarita Tagliaferri, Maria Elisa Mancuso, Roger Schutgens, Pål André HolmE, Jerzy Windyga, Irena Zupan, Victor Jimenez Yuste, Ramiro Nunez, Philippe de Moerloose, Erik Berntorp, Jan Astermark, Campbell Tait, Gerry Dolan
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 5, Pp 102514- (2024)
Background: People with hemophilia often experience pain and suffer from comorbidities related to their bleeding disorder. Consequently, unemployment due to disability is prevalent among people with hemophilia. Objectives: To explore associations bet
Externí odkaz:
https://doaj.org/article/bbbcde5173814e1f8d9095c20136a013
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 6, p 3095 (2022)
A type 3 von Willebrand disease (VWD) index patient (IP) remains mutation-negative after completion of the conventional diagnostic analysis, including multiplex ligation-dependent probe amplification and sequencing of the promoter, exons, and flankin
Externí odkaz:
https://doaj.org/article/451d22167bd3422e8b353d9ce42f593b
Autor:
Behnaz Pezeshkpoor, Nadja Sereda, Ann-Cristin Berkemeier, Isabell Matuschek, Nadine Schwarz, Peter L. Turecek, Silvia Horneff, Claudia Klein, Georg Goldmann, Natascha Marquardt, Thilo Albert, Jens Müller, Johannes Oldenburg
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:1503-1514
Autor:
Cedric Hermans, Jan Astermark, Manuela Carvalho, Gerry Dolan, Roseline d'Oiron, Pierre Fontana, Pål André Holme, Gili Kenet, Robert Klamroth, Maria Elisa Mancuso, Natascha Marquardt, Ramiro Nunez, Olga Katsarou, Ingrid Pabinger‐Fasching, Gabriele Quintavalle, Ryan Rodgers, Paul van der Valk, Jerzy Windyga, Victor Jimenez Yuste, Irena Preložnik Zupan
Publikováno v:
Haemophilia. 29:913-916
Autor:
Robert Klamroth, Cihan Ay, Philippe De Moerloose, Pierre Fontana, Jerzy Windyga, Jan Astermark, Erik Berntorp, Manuela Carvalho, Gerard Dolan, Cedric Hermans, Pål Andre Holme, Gili Kenet, Maria Elisa Mancuso, Natascha Marquardt, Ramiro Nunez, Ingrid Pabinger, Ryan Rodgers, Paul van der Valk, Victor Jimenez Yuste, Irena Preložnik Zupan
Publikováno v:
Haemophilia, Vol. 29, no.1, p. 21-32 (2023)
INTRODUCTION: As people with haemophilia (PWH) receive better treatment and live longer they are more likely to encounter cardiovascular disease (CVD) and other comorbidities. ESC guidelines for the acute management of patients presenting with acute
Autor:
Jamil, Hmida, Thomas, Hilberg, Sebastian, Koob, Natascha, Marquardt, Dieter C, Wirtz, Frank A, Schildberg, Johannes, Oldenburg, Andreas C, Strauss
Publikováno v:
Gait & Posture. 93:26-31
Patients with severe haemophilia suffer from bleeding-related joint changes in which the ankle joint is most frequently affected. In the resulting gait changes, the forefoot is involved by reducing the foot pressure. However, it is unclear which chan
Autor:
Pål Andre Holme, Philippe de Moerloose, Manuela Carvalho, Roseline d'Oiron, Paul R. van der Valk, Pierre Fontana, Olga Katsarou, Ingrid Pabinger, Robert Campbell Tait, Maria Elisa Elisa Mancuso, Natascha Marquardt, Cihan Ay, Cedric Hermans, Robert Klamroth, Jan Astermark, Gerard Dolan, Gili Kenet, Ramiro Núñez
Publikováno v:
Thrombosis and haemostasis, Vol. 122, no. 6, p. 905-912 (2022)
Introduction A second peak of inhibitors has been reported in patients with severe hemophilia A (HA) aged >50 years in the United Kingdom. The reason for this suggested breakdown of tolerance in the aging population is unclear, as is the potential im
Autor:
Ruwan Perera, Claudia Klein, T. Albert, Silvia Horneff, Georg Goldmann, Natascha Marquardt, Johannes Oldenburg
Publikováno v:
Journal of Current Medical Research and Opinion. 4:950-960
Introduction: The recombinant factor FVIII Fc fusion protein (rFVIIIFc) is a first-in-class extended half-life FVIII product to treat patients with hemophilia A. The safety, efficacy and prolonged half-life of rFVIIIFc was demonstrated in the phase 3
Publikováno v:
Blood. 140:11323-11324
Autor:
Claudia Klein, Georg Goldmann, Silvia Horneff, Johannes Oldenburg, Alexa Kersten, Bernd Pötzsch, Natascha Marquardt, Jens Müller
Publikováno v:
Hamburger Hämophilie Symposion Hamburg, Germany.